Suppressor of Cytokine Signaling 1 Gene Mutation Status as a Prognostic Biomarker in Classical Hodgkin Lymphoma

Oncotarget - United States
doi 10.18632/oncotarget.4829
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Circulating Dendritic Cells Deficiencies as a New Biomarker in Classical Hodgkin Lymphoma

British Journal of Haematology
Hematology
2018English

Role of ADAM10 as a CD30 Sheddase in Classical Hodgkin Lymphoma

Frontiers in Immunology
AllergyImmunology
2020English

Lymphocyte-Rich Classical Hodgkin Lymphoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2018English

Absence of the JAK2 V617F Activating Mutation in Classical Hodgkin Lymphoma and Primary Mediastinal B-Cell Lymphoma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2005English

Prognostic Significance of New Immunohistochemical Markers in Refractory Classical Hodgkin Lymphoma: A Study of 59 Cases

PLoS ONE
Multidisciplinary
2009English

Studies Identify Non-Hodgkin Lymphoma Suppressor

Cancer Discovery
Oncology
2015English

Hemophagocytic Lymphohistiocytosis in a Patient With Classical Hodgkin Lymphoma

Case Reports in Hematology
2016English

An Anaplastic T-Cell Lymphoma Mimicking Classical Hodgkin Lymphoma

Blood
BiochemistryImmunologyCell BiologyHematology
2018English

SOCS2 (Suppressor of Cytokine Signaling 2)

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy